Favorite Annette F's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Apr 29, 2026
- Accession no.
- 0000105770-26-000054
- Filed
- Apr 29, 2026
- Trade date
- Apr 27, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $859.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Favorite Annette FCIK 0001654975 | Officer (Sr. VP & Chief HR Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Common Stock | MOption exerciseAcquired | +2,817 | $83.47 | +$235,134.99 | 19,645.49 | Direct | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −2,817 | $305.20F1 | −$859,748.4 | 16,828.49 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Common Stock | MOption exerciseDisposed | −2,817 | $0.00 | $0 | 5,635 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price.
Referenced by the price of 1 transaction in Table I.